COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 613: Articles 6121-6130  | Next

Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Bazin, R., Rochette, S., Perreault, J., Fournier, M.-J., Gregoire, Y., Boivin, A., Lewin, A., Germain, M., Renaud, C.
10.1101/2022.08.15.22278798 — Posted: 2022-08-18
Two years of Covid-19: Excess mortality by age, region, gender, and race/ethnicity in the United States during the Covid-19 pandemic, March 1, 2020, through February 28, 2022
Faust, J. S., Du, C., Renton, B., Liang, C., Chen, A. J., Li, S.-X., Lin, Z., Nunez-Smith, M., Krumholz, H. M.
10.1101/2022.08.16.22278800 — Posted: 2022-08-18
Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis
Riley, C. S., Venkatesh, S., Dhand, A., Doshi, N. K., Kavak, K., Levit, E. E., Perrone, C., Weinstock-Guttman, B., Longbrake, E. E., MSReCOV Collaborative, , De Jager, P. L., Xia, Z.
10.1101/2022.08.17.22278896 — Posted: 2022-08-18
Uptake of Sotrovimab for prevention of severe COVID-19 and its safety in the community in England
Patone, M., Tibble, H., Snelling, A. J., Coupland, C., Sheikh, A., Hippisley-Cox, J.
10.1101/2022.08.17.22278893 — Posted: 2022-08-18
Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
Schrom, J., Marquez, C., Wang, C.-Y., Saxena, A., Mitchell, A., Ribeiro, S., Pilarowski, G., Nakamura, R., Rojas, S., Black, D., Contreras Oseguera, M., Castellanos Diaz, E., Payan, J., Rojas, S., Jones, D., Tulier-Laiwa, V., Zavaleta, A., Martinez, J., Chamie, G., Glaser, C., Jacobson, K., Petersen, M., DeRisi, J., Havlir, D.
10.1101/2022.08.17.22278913 — Posted: 2022-08-18
Prevalence and Characterization of Bacteria Present in the Nasopharynx of Outpatients with and without SARS-CoV-2
Shurko, J., Mares, C. A., Page, R. B., Lopez, K., Nguyen, V., Vanee, N., Mishra, P. K.
10.1101/2022.08.17.22278915 — Posted: 2022-08-18
Genetic diversity and spread dynamics of SARS-CoV-2 variants present in African populations
Mtetwa, D., Mutetwa, T. F., Manjengwa, T., Mazadza, A., Chikwambi, Z.
10.1101/2022.08.17.504290 — Posted: 2022-08-17
Natural variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics
Newby, M. L., Fogarty, C. A., Allen, J. D., Butler, J., Fadda, E., Crispin, M.
10.1101/2022.08.17.504157 — Posted: 2022-08-17
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Wamhoff, E.-C., Ronsard, L., Feldman, J., Hauser, B. M., Knappe, G. A., Romanov, A., Lam, E., St. Denis, K., Balazs, A. B., Schmidt, A., Lingwood, D., Bathe, M.
10.1101/2022.08.16.504128 — Posted: 2022-08-17
Antigen Specific T Cells in People with Obesity at Five Months Following ChAdOx1 COVID-19 Vaccination
Wrigley-Kelly, N. E., DeBarra, C., Shaamile, F., Holland, A., Shaw, L., Mallon, P. W. G., O'Connell, J., Hogan, A. E., O'Shea, D.
10.1101/2022.08.16.22278821 — Posted: 2022-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).